Epstein-Barr Virus and Human Disease

Related B-Cell Lymphoproliferative Disease After T Depleted Mismatched Bone Marrow Transplantation.- T-Cell Lymphomas in Patients with Chronic EBV Infection.- Morbidity of Epstein-Barr Virus Infection in Children.- Chronic Active Epstein-Barr Virus Infection in Children: Heterogeneity in Immune Defects and EBNA-Antibody Pattern.- P3HR-1-Like Nontransforming Virus in Saliva and Peripheral Blood Lymphocytes in Chronic Active EBV Infection.- Development of Two Monoclonal B-Cell Lymphomas in a Patient with Wiskott-Aldrich Syndrome.- Detection of Epstein-Barr Virus DNA in Saliva of Patients with AIDS and Related Disorders.- Detection in Normal Tonsils of a Novel B-Lymphocyte Population with a Burkitt-Like Phenotype.- Epstein-Barr Virus in the Lower Respiratory Tract.- Semiquantitative Analysis of Oropharyngeal EBV Shedding in Various Populations by Dot Blot Hybidization.- Prevalence of EBV in Household Contacts of Patients with Nasopharyngeal Carcinoma.- Changes in Lymphocyte Populations in Nasopharyngeal Carcinoma (NPC) Following Primary Radiotherapy with Subsequent a2-Interferon (IFN)-Therapy.- Some Questions Raised by Studies on Greenland Eskimos.- III. EBV DNA and Gene Expression.- Effects of S-Adenosylhomocysteine and Analogs on Epstein-Barr Virus (EBV)-Induced Transformation, EBV DNA Methylation, and Gene Expression.- Mapping EBV Early Antigens in Human Cells After Microinjection of Subgenomic DNA Clones.- Regulation of EBV Lytic Cycle Genes: Ms-Ea, A Trans-Activator of Gene Expression.- An EBV Early Promoter is Activated by Two Viral Encoded Transacting Factors EB1 and EB2.- Regulation of EBV Promoters.- Induction of Epstein-Barr Virus Genes in Raji Cells by 12-0-Tetradecanoyl Phorbol-13-Acetate Requires Ongoing Protein Synthesis.- Gene Expression in the BamHI E Region of EBV: A Brief Communication.- Development of a Set of EBV-Specific Antigens with Recombinant Gene Technology for Diagnosis of EBV-Related Malignant or Nonmalignant Diseases.- Detection of EBV DNA in Nude Mouse-Passaged Nasopharyngeal Carcinoma (NPC) Tissues.- Detection of Epstein-Barr Virus DNA in Nasopharyngeal Biopsies.- Plasmid Stabilization in Drosophila Cells Expressing EBNA1.- Identification and Characterization of Early Genes Involved in Epstein-Barr Virus Replication.- IV. EBV Proteins and Their Function.- Disruption of Latency by a Fragment of Rearranged EBV DNA: Evidence for Host Cell Regulation.- Variation in Epstein-Barr Virus Strains.- Identification and Characterization of Regulatory Proteins of EBV.- Characterization of the EBV Thymidine Kinase.- Characterization of an Epstein-Barr Virus (EBV) Membrane Antigen (56-62 kd) by a Monoclonal Antibody Which Revealed Some Antigenic Differences Among EBV Producer Cell Lines.- Epstein-Barr Virus Protein (LMP) Expression is Enhanced by Serum, TP A, or Butyrate.- Use of Synthetic Oligopeptides for the Identification and Characterization of Epstein-Barr Viral Membrane Proteins.- Phenotypic Characterization of C15, a Nude Mouse-Grown.- EBNA-1 Binds Specifically to Plasmids Containing a Synthetic 29 BP Binding Site.- Expression of the C-Terminal Part of an EBNA-2 Variant (2B) and Generation of Specific Sera.- Characterization of a Major EA-D Component of the EBV-Induced EA Complex.- Two Monoclonal Antibodies Against Epstein-Barr Virus Proteins.- Expression of the EBV-Encoded Membrane Protein (LMP) in Virally Transformed Cells.- Identification of EBV-Induced Polypeptides with Sera from Patients with SLE, RA, or IM.- Computerized Chou-Fasman Secondary Structure Analysis of EBV-Coded Membrane-Bound Proteins.- Cross Reactivity Between EBV and Herpes Simplex Virus.- V. Biological Aspects of EBV'Infections.- Biological Aspects of Epstein-Barr Virus-Induced B-Cell Immortalization.- Comparison of Interleukin-1 with Endogenous B-Cell Factors for Effects on Lymphoma Cell Growth After EBV Conversion.- A Nude Mouse-Grown NPC Tumor Produces Interleukin-1.- Autoantibody Production by Human B Lymphocytes Which Spontaneously Proliferate.- Distribution of Epstein-Barr Virus Strains with Different EBNA 2 Genotypes in Burkitt-Endemic Areas.- Biological Properties of Epstein-Barr Virus Recovered from Epithelial Cells Transfected with DNA Prepared from a Nasopharyngeal Carcinoma-Derived EBV.- Characterization of the Suppressor Effect of B-95-8 Virus On EA Inducing Capability of P3HR-1 Virus.- Epstein-Barr Virus Genome Activation in Latently Infected Cells by Calcium Ionophores.- Effects of Non-Ionizing Radiation on EBV Non-Producing Cells.- Cytofluorometric Study of Epstein-Barr Virus Receptor Expression on Human T Lymphocyte Populations.- Isolation of a Normal B-Cell Subset with a Burkitt-Like Pheno-type and Examination of Its Interaction with EB Virus.- Superinfecting Activity of the B95-8 Isolate of Epstein-Barr Virus.- Polyclonal Activation of B Lymphocytes After EB Virus Infection.- VI. Immunology of EBV.- Cellular Controls Over EBV Infection.- HLA-Antigens and Cell-Mediated Immunity to EBV.- Interleukins and Interferons During EBV Infection.- Primary Killer-Cell Defect in Patients with Chronic Active Epstein-Barr Virus (EBV) Infection and Acquired Hyper IgG1.- Lymphatic Tissue Response to Persistent Active Virus Infections in Immune Deficiency.- A Reevaluation of EBV-Specific T Cell-Mediated Immunity in Malaria-Endemic and Non-Endemic Regions of Papua, New Guinea.- Synergism Between Epstein-Barr Virus and B-Cell Growth Factor.- Monocytes and a Monocyte Product Regulate Epstein-Barr Virus-Induced B-Cell Activation.- Inhibition of Interleukin-2 Synthesis by Infectious Mononucleosis-Associated IgG Blocking Factor.- Induction of Nonspecific Suppressor Cells by Different Epstein-Barr Virus Antigens.- Stimulation of EB Virus-Specific Helper T Cells by Burkitt's Lymphoma and Lymphoblastoid Cell Lines.- Raji Cells Release Soluble Factors Which Modulate NK Activity of Human Peripheral Blood Lymphocytes.- Frequencies of Reactive Cells to Autologous Lymphoblastoid Cells in Males with X-Linked Lymphoproliferative Syndrome.- Autoantibody Generation During Infectious Mononucleosis.- Epstein-Barr Virus Serology: Specificities of Sera Against EBNA 1 and EBNA 2.- X-Linked Lymphoproliferative Patient Antibody Response to a Synthetic Peptide of Epstein-Barr Nuclear Antigen.- Differential Expression of EB-Viral and Cellular Surface Markers on Burkitt Lymphoma and Lymphoblastoid Cell Lines.- VII. Cofactors Associated with EBV Infections.- Role of Co-Factors in the Etiology of EBV-Related Diseases.- EBV DNA Structure and Oncogene Expression in EBV-Associated Malignancies.- NIH 3T3 Cell Transformation by DNAs from Lymphoma Cells and from Epstein-Barr Virus-Immortalized Human Lymphocytes.- Volatile Nitrosamines in Food Samples Collected in Three High Risk Areas for Nasopharyngeal Carcinoma.- Induction of Epstein-Barr Virus in Raji Cells by Plasmodium falciparum and by Normal Red Blood Cells.- An Environmental Plant Factor Enhancing Epstein-Barr Virus-Induced Events in East Africas.- Chemical Carcinogen Enhancement of Epstein-Barr Virus (EBV)-Induced Transformation: Association with EBV Genome Amplification.- Geopathological Coincidence of Burkitt's Lymphoma and Endemic Kaposi's Sarcoma in Western Kenya.- Model Studies Related to Nasopharyngeal Carcinoma.- Chronic HTLV-III Infection in EBV-Genome Containing B-Cell Lines.- VIII. Control of EBV Infections.- Preparation of an EBV Vaccine to Prevent Oncogenesis: An Update.- Antigenic Analysis of the EBV Major Membrane Protein (gp350/gp220) Expressed in Yeast and Mammalian Cells.- Expression and Analysis of EBV gp350 in the Yeast, Saccharomyces cerevisiae.- Expression of the Major Envelope Glycoprotein gp350/220 of Epstein-Barr Virus by a Recombinant Varicella Zoster Virus.- Secretion of the Two Major Epstein-Barr Viral Glycoproteins (gp250/350) from Recombinant Chinese Hamster Ovary Cells.- Post-Radiotherapy Adjuvant Chemotherapy of Regionally Advanced UNPC: Increase in Disease Free Survival.- Inhibition of Epstein-Barr Virus Replication by 1-? -D-Arabino-furanosyl-E-5-(2-BROMOVINYL) Uracil In Vitro.- EBV-Specific Transfer Factor in the Treatment of Abdominal Burkitt's Lymphoma in Ghana, West Africa.- Circulating Interferon in EBV Infections.- Inhibition of Epstein-Barr Virus Release by Anti-Ma Antibody.- Role of CD8+ and CD8- Cytolytic Effectors in IL2 Reversal of Cyclosporin-Inhibited EBV-B-Cell Cytotoxicity.- Rationale for Intravenous Gamma-Globulin Therapy of Persistent Lymphotropic Viral Infections.- List of Participants.